NO985809D0 - Modifisert form av R(-)-N-(4,4-di(3-metyltien-2-yl)but-3-enyl)-nipekotinsyrehydrokloridet - Google Patents

Modifisert form av R(-)-N-(4,4-di(3-metyltien-2-yl)but-3-enyl)-nipekotinsyrehydrokloridet

Info

Publication number: NO985809D0
Authority: NO; Norway
Prior art keywords: methylthien; enyl; modified form; acid hydrochloride; nipecotinic acid
Prior art date: 1996-06-14

Application number

NO985809A

Other languages

English (en)

Other versions

NO985809L (no

NO316889B1 (no

Inventor

Preben Ahrndt

Henning B Rge Petersen

Vincent H Chang

Kimberly Ann Allen

Michael H Chain

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-14

Filing date

1998-12-11

Publication date

1998-12-11

1998-12-11 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1998-12-11 Publication of NO985809L publication Critical patent/NO985809L/no

1998-12-11 Publication of NO985809D0 publication Critical patent/NO985809D0/no

2004-06-14 Publication of NO316889B1 publication Critical patent/NO316889B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO19985809A 1996-06-14 1998-12-11 Vannfri krystallform av R(-)-N-(4,4-di(3-metyltien-2-yl)but-3-enyl) -nipekotinsyrehydrokloridet, fremgangsmate for fremstilling derav, farmasoytisk preparat som omfatter et slikt krystallinsk salt, og anvendelse av et slikt krystallinsk salt til fremstill NO316889B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK66196		1996-06-14
PCT/DK1997/000244 WO1997047619A1 (en)	1996-06-14	1997-06-03	Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride

Publications (3)

Publication Number	Publication Date
NO985809L NO985809L (no)	1998-12-11
NO985809D0 true NO985809D0 (no)	1998-12-11
NO316889B1 NO316889B1 (no)	2004-06-14

Family

ID=8096101

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19985809A NO316889B1 (no)	1996-06-14	1998-12-11	Vannfri krystallform av R(-)-N-(4,4-di(3-metyltien-2-yl)but-3-enyl) -nipekotinsyrehydrokloridet, fremgangsmate for fremstilling derav, farmasoytisk preparat som omfatter et slikt krystallinsk salt, og anvendelse av et slikt krystallinsk salt til fremstill

Country Status (20)

Country	Link
EP (1)	EP0906309B1 (no)
JP (1)	JP2000511909A (no)
CN (1)	CN1636565A (no)
AR (1)	AR008236A1 (no)
AT (1)	ATE223405T1 (no)
AU (1)	AU723267B2 (no)
BR (1)	BR9709725A (no)
CZ (1)	CZ295578B6 (no)
DE (1)	DE69715196T2 (no)
DK (1)	DK0906309T3 (no)
ES (1)	ES2181002T3 (no)
HU (1)	HUP9904035A3 (no)
IL (1)	IL127469A (no)
NO (1)	NO316889B1 (no)
PL (1)	PL190858B1 (no)
PT (1)	PT906309E (no)
RU (1)	RU2177478C2 (no)
UA (1)	UA52661C2 (no)
WO (1)	WO1997047619A1 (no)
ZA (1)	ZA975266B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5914333A (en) *	1996-07-31	1999-06-22	Novo Nordisk A/S	Treatment of psychotic disorders
JP2001511450A (ja) *	1997-08-01	2001-08-14	エランコーポレーシヨンピーエルシー	チアガビンを含有する制御放出性の医薬組成物
IE970588A1 (en)	1997-08-01	2000-08-23	Elan Corp Plc	Controlled release pharmaceutical compositions containing tiagabine
CN1314684C (zh) *	2003-12-24	2007-05-09	中国科学院上海有机化学研究所	噻加宾及其消旋体和s－构型的合成方法及其无定形粉末的制法
GB0402118D0 (en) *	2004-01-30	2004-03-03	Merck Sharp & Dohme	Polymorphic forms of a GABAA agonist
WO2005092886A1 (en) *	2004-03-29	2005-10-06	Ranbaxy Laboratories Limited	Process for the preparation of amorphous form of tiagabine
US20080064727A1 (en) *	2006-08-18	2008-03-13	Cephalon, Inc.	Crystalline forms of tiagabine hydrochloride

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK288385D0 (da) *	1985-06-26	1985-06-26	Novo Industri As	Aminosyrederivater
DK58291D0 (da) *	1991-04-02	1991-04-02	Novo Nordisk As	Krystalinsk stof og dets fremstilling

1997
- 1997-03-06 UA UA98126589A patent/UA52661C2/uk unknown
- 1997-06-03 DK DK97927006T patent/DK0906309T3/da active
- 1997-06-03 CN CNA2004100926232A patent/CN1636565A/zh active Pending
- 1997-06-03 WO PCT/DK1997/000244 patent/WO1997047619A1/en active IP Right Grant
- 1997-06-03 HU HU9904035A patent/HUP9904035A3/hu unknown
- 1997-06-03 PT PT97927006T patent/PT906309E/pt unknown
- 1997-06-03 PL PL330424A patent/PL190858B1/pl unknown
- 1997-06-03 EP EP97927006A patent/EP0906309B1/en not_active Expired - Lifetime
- 1997-06-03 DE DE69715196T patent/DE69715196T2/de not_active Expired - Lifetime
- 1997-06-03 IL IL12746997A patent/IL127469A/xx not_active IP Right Cessation
- 1997-06-03 BR BR9709725A patent/BR9709725A/pt not_active IP Right Cessation
- 1997-06-03 JP JP10501077A patent/JP2000511909A/ja not_active Ceased
- 1997-06-03 AT AT97927006T patent/ATE223405T1/de active
- 1997-06-03 AU AU31653/97A patent/AU723267B2/en not_active Expired
- 1997-06-03 CZ CZ19984019A patent/CZ295578B6/cs not_active IP Right Cessation
- 1997-06-03 ES ES97927006T patent/ES2181002T3/es not_active Expired - Lifetime
- 1997-06-03 RU RU99100703/04A patent/RU2177478C2/ru not_active IP Right Cessation
- 1997-06-13 ZA ZA9705266A patent/ZA975266B/xx unknown
- 1997-06-13 AR ARP970102614A patent/AR008236A1/es active IP Right Grant
1998
- 1998-12-11 NO NO19985809A patent/NO316889B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69715196D1 (de)	2002-10-10
EP0906309B1 (en)	2002-09-04
EP0906309A1 (en)	1999-04-07
AU3165397A (en)	1998-01-07
ATE223405T1 (de)	2002-09-15
PT906309E (pt)	2002-12-31
HUP9904035A3 (en)	2000-07-28
NO985809L (no)	1998-12-11
PL330424A1 (en)	1999-05-10
IL127469A (en)	2001-01-11
CZ295578B6 (cs)	2005-08-17
IL127469A0 (en)	1999-10-28
UA52661C2 (uk)	2003-01-15
JP2000511909A (ja)	2000-09-12
CZ401998A3 (cs)	1999-06-16
WO1997047619A1 (en)	1997-12-18
HUP9904035A2 (hu)	2000-05-28
BR9709725A (pt)	1999-08-10
ES2181002T3 (es)	2003-02-16
AU723267B2 (en)	2000-08-24
NO316889B1 (no)	2004-06-14
DK0906309T3 (da)	2002-12-16
CN1636565A (zh)	2005-07-13
RU2177478C2 (ru)	2001-12-27
ZA975266B (en)	1998-02-04
DE69715196T2 (de)	2003-05-15
AR008236A1 (es)	1999-12-29
PL190858B1 (pl)	2006-02-28

Publication	Publication Date	Title
PT925298E (pt)	2004-07-30	Derivados 6,6-hetero-biciclicos substituidos
DE69933287D1 (de)	2006-11-02	12,13-modifizierte epothilon-derivate
ID29241A (id)	2001-08-16	Turunan-turunan kinolin teranelasi-1,2
ATE340176T1 (de)	2006-10-15	Substituierte 6,5-heterobicyclische-derivate
PT1000048E (pt)	2003-03-31	Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
ID26310A (id)	2000-12-14	Produksi kontinyu 1,3-dioksolan-2-ona
ATE231847T1 (de)	2003-02-15	Substituierte 1,2,3,4- tetrahydronaphthalinderivate
DK1254118T3 (da)	2006-03-20	Substituerede 1,2,3,4-tetrahudroquinolin-2-carboxylsyrederivater
NO20003825D0 (no)	2000-07-26	1,3,4 - oxadiazolonderivater
DE60025958D1 (de)	2006-04-20	14,15-beta-methylen substituierte androgene
NO985809D0 (no)	1998-12-11	Modifisert form av R(-)-N-(4,4-di(3-metyltien-2-yl)but-3-enyl)-nipekotinsyrehydrokloridet
ATE234839T1 (de)	2003-04-15	4,5-azolo-oxindole
ID26573A (id)	2001-01-18	Bentuk ke-vi dari 5, 6-dikloro-2-(isopropilamino) 1-(b-l-ribofurasonil)-1h-benzimidazol
ID27686A (id)	2001-04-19	Turunan 3-(2-okso-[1,3]bipirolidinil-3-ildenametil)-sefem
ATE243218T1 (de)	2003-07-15	2''-deoxyhygromycinderivate
DE69915055D1 (de)	2004-04-01	Antitumorale 1,5-diazaanthraquinone
NO20005856L (no)	2001-05-30	Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
FI980106A0 (fi)	1998-01-19	Ytbehandlingsfoerfarande i synnerhet foer foerbaettring av barriaer- och tryckningsegenskaperna hos banor
DE69908923D1 (de)	2003-07-24	1,3,4-thiadiazolylazofarbstoffe-enthaltende tintenzusammensetzungen
ID23006A (id)	1999-12-30	13-dihidro-3' aziridino antrasiklina
DE59902656D1 (de)	2002-10-17	Abspielgerät
CA2257931A1 (en)	1997-12-18	Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
FI980405A0 (fi)	1998-02-23	Industriellt, kontinuerligt foerfarande foer framstaellning av "gravkalk"
UA3680S (uk)	2000-10-16	Гітара "інтеркрасстер"

Legal Events

Date	Code	Title	Description
2012-01-23	MM1K	Lapsed by not paying the annual fees